Skip to main content
. 2024 May 13;14(10):1009. doi: 10.3390/diagnostics14101009

Table 2.

Details of antiosteoporosis medications (overlapped).

AOM Group (n = 49)
Antiosteoporosis Medication Mean Duration (Months, Minimum–Maximum)
BP/Dmab (n = 36)
Oral BPs (24) 41.3 (1–212)
Injected BPs (4) 17.5 (4–29)
Dmab (7) 32.3 (2–66)
Sequential therapy (1) over 12
Non-BP/Dmab (n = 13)
Alfacalcidol (7) 53.0 (18–96)
Bazedoxifene acetate (2) 15.5 (13–18)
Tamoxifen (2) 43.0 (12–74)
Teriparatide (1) 7
Trastuzumab (1) 12

AOM, antiosteoporosis medication.